000 00985 a2200277 4500
005 20250517164147.0
264 0 _c20180116
008 201801s 0 0 eng d
022 _a1097-6868
024 7 _a10.1016/j.ajog.2017.07.014
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHeyborne, Kent D
245 0 0 _aDo maternal obesity or smoking explain the lack of effectiveness of 17-alpha hydroxyprogesterone caproate?
_h[electronic resource]
260 _bAmerican journal of obstetrics and gynecology
_c11 2017
300 _a621 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aCaproates
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHydroxyprogesterones
650 0 4 _aPregnancy
650 0 4 _aSmoking
700 1 _aAllshouse, Amanda A
773 0 _tAmerican journal of obstetrics and gynecology
_gvol. 217
_gno. 5
_gp. 621
856 4 0 _uhttps://doi.org/10.1016/j.ajog.2017.07.014
_zAvailable from publisher's website
999 _c27388220
_d27388220